Characteristics | Total | MiR-7 expression | χ 2 | P value | |
---|---|---|---|---|---|
 |  | - | + |  |  |
Gender | Â | Â | Â | 0.134 | 0.714 |
Male | 43 | 22 | 21 | Â | Â |
Female | 9 | 4 | 5 | Â | Â |
Age | Â | Â | Â | 0.115 | 0.734 |
<55†| 11 | 6 | 5 |  |  |
≥55 | 41 | 20 | 21 |  |  |
Stage | Â | Â | Â | 6.240 | 0.012 |
Limited disease | 25 | 8 | 17 | Â | Â |
Extensive disease | 27 | 18 | 9 | Â | Â |
Drug-sensitivity | Â | Â | Â | 3.733 | 0.053 |
Sensitive group | 25 | 10 | 15 | Â | Â |
Resistant group | 22 | 15 | 7 | Â | Â |
Kir2.1 | Â | Â | Â | 13.175 | <0.001 |
Negative | 29 | 8 | 21 | Â | Â |
Positive | 23 | 18 | 5 | Â | Â |
ABCC1 | Â | Â | Â | 9.321 | 0.002 |
Negative | 25 | 7 | 18 | Â | Â |
Positive | 27 | 19 | 8 | Â | Â |